What made Moderna stock pop 10% on Tuesday?

Published on 9 Apr 2024 on Invezz

Jefferies analyst made positive remarks on MRNA-4157 today. Moderna stock is now up close to 30% versus its year-to-date low.

Read the rest of the article

Start tracking your investments with Statfolio

mRNA Is Promising A Breakthrough In Fighting Cancer When it comes to cancer, there’s innovation b...

Benzinga via Yahoo Finance 29 Apr 2024

Moderna MRNA will report first-quarter 2024 results on May 2, before the opening bell. In the las...

Zacks via Yahoo Finance 29 Apr 2024

Corporate earnings came to the market’s rescue in the past week, helping to overcome rate fears. ...

Benzinga 29 Apr 2024

Moderna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has recently sold a significant portion of hi...

Investing.com 27 Apr 2024

Arvinas, Inc. (ARVN) is expected to deliver a year-over-year increase in earnings on higher reven...

Zacks via Yahoo Finance 26 Apr 2024

Last year, Douglas Ingram, the president and CEO of Sarepta Therapeutics (Nasdaq: SRPT), reported...

The Business Journals 26 Apr 2024

Moderna (MRNA) stock gains as company announces a deal with AI company OpenAI to accelerate the d...

Seeking Alpha 24 Apr 2024

Moderna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London p...

Benzinga 23 Apr 2024

In the last year, many Moderna, Inc. (NASDAQ:MRNA) insiders sold a substantial stake in the compa...

Simply Wall St. via Yahoo Finance 21 Apr 2024

Moderna , Inc. (NASDAQ:MRNA) Director Noubar Afeyan has sold a total of $1,550,703 worth of compa...

Investing.com 19 Apr 2024